Connect with us
DAPA Banner

Business

Cento Fine Foods sued over alleged San Marzano ‘tomato fraud’

Published

on

Cento Fine Foods sued over alleged San Marzano 'tomato fraud'

A major food brand is being sued over claims it falsely marketed its canned tomatoes as premium “San Marzano” products.

Cento Fine Foods, based in New Jersey, is facing a proposed class action lawsuit claiming it misled consumers by labeling its tomatoes as “certified” San Marzano despite allegedly failing to meet the strict standards associated with the variety, according to a May 4 complaint filed in federal court in California.

Advertisement

“San Marzano tomatoes are considered the Ferrari or Prada of canned tomato varieties,” the lawsuit states, quoting Martha Stewart’s website. “Loyalists say they are well worth the higher price tag compared to other Italian or domestically produced options.”

RISING COSTS, LOYAL CUSTOMERS: INSIDE A STATEN ISLAND RESTAURANT EMPIRE

Cento san-marzano-tomatoes

The complaint, filed May 4 in federal court in California, accuses Cento Fine Foods of falsely labeling its tomatoes as “certified.” (U.S. District Court For the Northern District of California)

“San Marzano” refers to both a variety of tomato and a region in Italy where they are traditionally grown. The tomatoes are a type of plum tomato, typically longer and more slender than standard varieties, with a distinct pointed end and fewer seeds, according to Martha Stewart’s website.

Under European Union rules, authentic San Marzano tomatoes carry a “Protected Designation of Origin” (DOP) status — similar to products like Champagne — meaning they must be grown and processed in a designated region of southern Italy and meet strict production standards.

Advertisement

The complaint alleges Cento’s use of “certified” falsely suggests the products are officially recognized San Marzano tomatoes, calling the brand “the primary culprit of this tomato fraud in the United States.”

“Defendant’s claims that its tomatoes are ‘certified’ ‘San Marzano’ tomatoes misleadingly convey that the product is the famous San Marzano tomato certified by and exceeding the standards of Consorzio di Tutela del Pomodoro San Marzano dell’Agro Sarnese-Nocerino when in fact the product does not meet that standard,” the complaint states.

COSTCO RECALLS POPULAR PRODUCT IN 2 STATES OVER POTENTIAL INGREDIENT MIX-UP

San Marzano tomatoes are pictured in Campania, Italy.

San Marzano tomatoes are pictured in Campania, Italy. (DeAgostini/Getty Images / Getty Images)

The plaintiffs say they bought Cento’s San Marzano tomatoes believing they were “authentic.” They allege the products fell short of true DOP standards and say they “would never have purchased Cento San Marzanos” if they had known.

Advertisement

The lawsuit seeks at least $25 million in restitution and changes to Cento’s business practices.

In a statement to “Good Morning America,” an attorney for Cento pushed back on the allegations.

“We believe this claim is entirely without merit. We have previously successfully defended a comparable lawsuit in New York federal court and will defend this claim vigorously as well, including seeking prompt dismissal,” the attorney said.

POPULAR POTATO CHIPS RECALLED DUE TO SALMONELLA FEARS

Advertisement
Cento san-marzano-tomatoes

An attorney for Cento pushed back on the allegations. (U.S. District Court For the Northern District of California)

The company has previously faced similar claims. In a 2019 class action lawsuit, Cento said it “refutes” allegations that its tomatoes are not genuine.

“Our fields and farmers are audited by an independent third party in Italy who assures that the tomatoes are grown in the rich fertile soil of Sarnese-Nocerino at the base of Mt. Vesuvius in Campagna,” the company said at the time.

CLICK HERE TO GET FOX BUSINESS ON THE GO

That case was dismissed in 2020, “Good Morning America” reported.

Advertisement

Cento Fine Foods did not immediately respond to FOX Business’ request for comment.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Without Regime Change, Can We Ever Really Trust Iran?

Published

on

Without Regime Change, Can We Ever Really Trust Iran?

So it appears that America and Iran are moving closer on a proposal to restart peace talks. Yet it seems so indirect, like a carom shot in pool.

Who can be sure? As I read it, from the media reports, principally Axios and the Wall Street Journal, America and Iran are working on a one-page framework to restart negotiations.

So there has to be agreement on the one-pager, and if there is agreement, then actual negotiations might begin next week at Islamabad or Geneva, Switzerland.

Advertisement

So if I get this even remotely right, and I don’t have much direct information, we are negotiating in order to begin negotiating. Well, okay.

And if the negotiations don’t work out you can be sure that all bombing hell will descend on Iran — much worse than anything they’ve seen before.

As the president said on this whole thing this afternoon: “We’re in good shape. And, now we’re doing well. Now we have to get what we have to get. If we don’t do that, we’ll have to go a big step further. But with that being said, they want to make a deal. We’ve had very good talks over the last 24 hours, and it’s very possible that we’ll make a deal.”

Meanwhile, Project Freedom has been paused which frankly disappoints me because I had hoped our great United States Navy would have been able to ramp up 50 to 100 or more commercial ships through the Strait of Hormuz.

Advertisement

And if there’s a 30-day period of negotiations, the United States Navy’s blockade would gradually be lifted. This too is disappointing.

At this point, though, the blockade is very much still in place. So again, we’ll wait to see more information. Another piece to this Iran story is President Trump’s trip to Communist China. Is this part of the negotiation process?

My hope has always been that America would exert complete control over the whole Arabian Gulf, including the Hormuz Strait for some considerable period of time.

Now that may still happen. And of course our military forces are not going any place. And when Mr. Trump says it’s very possible a deal can be reached, then I’ll go along with that. I’ve supported him the whole time. I know he’s not going to make a bad deal.

Advertisement

I know he’ll insist on the key red lines of stopping Iranian enrichment of uranium. And transferring enriched uranium from Iran to the United States. And I believe the president would never allow Iran to have control over shipping in the Strait of Hormuz.

What’s more, I’m certain he will insist that Iran stop its state-sponsored terrorism, and that war against Israel and for that matter its war against the United States.

Yet there is a fear among our Gulf allies, that there’s too much uncertainty and the American team.

And so it would seem, regrettably, that there will be no major regime change in Iran. Which of course once again raises the issue of verification and trust.

Advertisement

Iran has never allowed either. And right now that may be the toughest part of this whole story.

Continue Reading

Business

Opinion: Fake infiltration an AI disorder

Published

on

Opinion: Fake infiltration an AI disorder

OPINION: A worrying trend is starting to rear its head in AI, with real-world implications.

Continue Reading

Business

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls.

Published

on

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls.

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls.

Continue Reading

Business

National Health Investors, Inc. 2026 Q1 – Results – Earnings Call Presentation (NYSE:NHI) 2026-05-07

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q1: 2026-05-04 Earnings Summary

EPS of $0.77 misses by $0.09

 | Revenue of $115.13M (28.93% Y/Y) beats by $9.78M

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Advertisement
Continue Reading

Business

SEC Proposes to Eliminate Quarterly Reporting Requirement for Public Companies

Published

on

SEC Proposes to Eliminate Quarterly Reporting Requirement for Public Companies

Under the proposal, public companies would have the option to file reports semiannually, rather than on a quarterly basis

Continue Reading

Business

Israel strikes Beirut for the first time since the ceasefire

Published

on

Israel strikes Beirut for the first time since the ceasefire


Israel strikes Beirut for the first time since the ceasefire

Continue Reading

Business

Polycab shares jump 6% as post-earnings target prices go up to Rs 10,500. Should you buy now?

Published

on

Polycab shares jump 6% as post-earnings target prices go up to Rs 10,500. Should you buy now?
Polycab India shares surged 6% to Rs 8,938.70 on BSE on Thursday morning after the wires and cables maker delivered a quarter that beat street estimates on nearly every metric, prompting a flurry of target price upgrades from brokerages, with Citi setting the highest bar at Rs 10,500.

The rally follows Polycab’s Q4 consolidated revenue rising 27% year-on-year (YoY), while EBITDA grew 13% YoY. The numbers impressed analysts as they came despite geopolitical disruptions, a March demand slowdown, and channel destocking amid raw material volatility.

Citi, the most bullish on the Street, raised its target price from Rs 9,500 to Rs 10,500 while maintaining a Buy rating, citing execution quality as the key differentiator. “Market share gains reflect execution and scale advantage,” the brokerage said, adding that Polycab passed on the entire impact of raw material costs by the first fortnight of January, with no inventory gains due to hedging.

Polycab’s share of the organised cables and wires market has risen to 30–31%, marking a gain of 300–400 basis points year-on-year, a trend Jefferies highlighted while naming the company its top pick. “Organised market share rose to 30–31%, up 400 bps YoY, as C&W volume grew 18% in FY26,” Jefferies said, raising its target price to Rs 9,770 from Rs 8,950 and projecting a FY26–29 EPS CAGR of 21%. The brokerage described the stock as “a play on power and housing.”

Advertisement

Motilal Oswal raised its target price to Rs 9,800 from Rs 9,350, estimating revenue and EBITDA CAGRs of 19% and PAT growth of around 18% over FY26-28. The brokerage expects operating margins to remain in the 13.5-14% range. It also estimates the company’s net cash balance will rise to Rs 47.8 billion by FY28 from Rs 41.5 billion in FY26, underscoring the financial strength supporting the growth story.


Nuvama raised FY27/28 EPS estimates by 3-5% to reflect the beat, projecting revenue, EBITDA, and PAT CAGRs of 18%, 17%, and 17%, respectively, over FY26-29. The brokerage lifted its target to Rs 9,740 from Rs 9,420, valuing the stock at 40x March 2028 estimated EPS. At the current market price, Polycab trades at 34.5x FY28 estimated EPS.
JM Financial, raising its target to Rs 9,700 from Rs 9,200 at 42x March 2028 EPS, flagged cables and wires capacity utilisation at mid-70s as providing reasonable certainty of meeting any unanticipated demand pickup, effectively a buffer the market is not fully pricing in.Beyond cables and wires, the FMEG segment is emerging as a meaningful second engine. Elara Capital, which maintained Accumulate with a target of Rs 8,920, noted that FMEG surged 39% YoY, driven by solar products, and turned EBIT positive in FY26 for the first time. The segment’s turnaround removes a long-standing drag on overall profitability.

Looking further out, Citi flagged that Polycab’s extra-high voltage capacity is set to be commissioned by year-end, with revenue expected to start flowing in FY28, a potential re-rating catalyst that the current target prices may not fully capture.

The one note of caution across brokerages is margin pressure from a shift in sales mix toward lower-margin exports and higher institutional sales, which clipped EBITDA growth relative to revenue.

Elara specifically highlighted this, even as it maintained a positive view on the stock’s longer-term prospects.

Advertisement

With an aggressive Rs 60-80 billion capex pipeline over five years, a dominant and still-growing market share position, and the FMEG business finally in the black, Polycab is making a case that Thursday’s 6% move may be the beginning of a longer re-rating and not the end of it.

Continue Reading

Business

Australian energy stocks slip on domestic gas reservation plan

Published

on


Australian energy stocks slip on domestic gas reservation plan

Continue Reading

Business

Japanese chip and tech shares surge as AMD earnings spark AI optimism

Published

on


Japanese chip and tech shares surge as AMD earnings spark AI optimism

Continue Reading

Business

China may try ’manoeuvring’ over Taiwan issue at Trump meeting, official says

Published

on

China may try ’manoeuvring’ over Taiwan issue at Trump meeting, official says


China may try ’manoeuvring’ over Taiwan issue at Trump meeting, official says

Continue Reading

Trending

Copyright © 2025